Calidi Biotherapeutics, Inc. Increase (Decrease) in Fair Value of Price Risk Fair Value Hedging Instruments
Calidi Biotherapeutics, Inc. (CLDI) reported Increase (Decrease) in Fair Value of Price Risk Fair Value Hedging Instruments of $2.70 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Notes
us-gaap:IncreaseDecreaseInFairValueOfPriceRiskFairValueHedgingInstruments1 · last filed 2024-11-12
- 2024-09-30: Increase (Decrease) in Fair Value of Price Risk Fair Value Hedging Instruments 9 month $2.70M.
- 2024-06-30: Increase (Decrease) in Fair Value of Price Risk Fair Value Hedging Instruments 6 month $100.00K.
| Period end | Increase (Decrease) in Fair Value of Price Risk Fair Value Hedging Instruments 6 month | Increase (Decrease) in Fair Value of Price Risk Fair Value Hedging Instruments 9 month |
|---|---|---|
| 2024-09-30 | $2.70M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $100.00K 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |